These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20567893)

  • 21. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
    Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
    J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
    Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The association of COMT and DRD2 gene polymorphisms with a cognitive ability to understand others in schizophrenic patients].
    Alfimova MV; Golimbet VE; Korovaĭtseva GI; Aksenova EV; Lezheĭko TV; Abramova LI; Kolesina NIu; Anua IM; Savel'eva TM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(8):50-6. PubMed ID: 24077552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation.
    Jääskeläinen SK; Lindholm P; Valmunen T; Pesonen U; Taiminen T; Virtanen A; Lamusuo S; Forssell H; Hagelberg N; Hietala J; Pertovaara A
    Pain; 2014 Oct; 155(10):2180-7. PubMed ID: 25180011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.
    Ramsay H; Barnett JH; Miettunen J; Mukkala S; Mäki P; Liuhanen J; Murray GK; Jarvelin MR; Ollila H; Paunio T; Veijola J
    PLoS One; 2015; 10(6):e0127602. PubMed ID: 26114663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of genetic variants reveal inverse modulation patterns of dopamine system on brain gray matter volume and resting-state functional connectivity in healthy young adults.
    Xu J; Qin W; Liu B; Jiang T; Yu C
    Brain Struct Funct; 2016 Nov; 221(8):3891-3901. PubMed ID: 26498330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach.
    Reuter M; Peters K; Schroeter K; Koebke W; Lenardon D; Bloch B; Hennig J
    Behav Brain Res; 2005 Oct; 164(1):93-9. PubMed ID: 16026865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association study of functional polymorphisms of dopaminergic pathway in epilepsy-related factors of temporal lobe epilepsy in Brazilian population.
    Alcantara JA; Vincentis S; Kerr DS; Dos Santos B; Alessi R; van der Linden H; Chaim T; Serpa MH; Busatto GF; Gattaz WF; Demarque R; Valente KD
    Eur J Neurol; 2018 Jun; 25(6):895-901. PubMed ID: 29575277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic Genetic Polymorphisms Predict Rule-based Category Learning.
    Byrne KA; Davis T; Worthy DA
    J Cogn Neurosci; 2016 Jul; 28(7):959-70. PubMed ID: 26918585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation.
    Noohi F; Boyden NB; Kwak Y; Humfleet J; Müller ML; Bohnen NI; Seidler RD
    Neuropsychologia; 2016 Apr; 84():222-34. PubMed ID: 26926580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg H
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):446-50. PubMed ID: 16427255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of traumatic life events, cognitive biases and variation in dopaminergic genes on psychosis proneness.
    Kotowicz K; Frydecka D; Gawęda Ł; Prochwicz K; Kłosowska J; Rymaszewska J; Samochowiec A; Samochowiec J; Szczygieł K; Pawlak-Adamska E; Szmida E; Cechnicki A; Misiak B
    Early Interv Psychiatry; 2021 Apr; 15(2):248-255. PubMed ID: 31889426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder.
    Heidinger BA; Cameron JD; Vaillancourt R; De Lisio M; Ngu M; Tasca GA; Chyurlia L; Doucet É; Doucette S; Maria Obregón Rivas A; Goldfield GS
    Gene; 2021 May; 781():145538. PubMed ID: 33631245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional connectivity in healthy subjects is nonlinearly modulated by the COMT and DRD2 polymorphisms in a functional system-dependent manner.
    Tian T; Qin W; Liu B; Jiang T; Yu C
    J Neurosci; 2013 Oct; 33(44):17519-26. PubMed ID: 24174684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistasis effects of dopamine genes on interval timing and reward magnitude in humans.
    Balcı F; Wiener M; Cavdaroğlu B; Branch Coslett H
    Neuropsychologia; 2013 Jan; 51(2):293-308. PubMed ID: 22903038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catechol-o-methyl transferase modulates cognition in late life: evidence and implications for cognitive enhancement.
    Sambataro F; Pennuto M; Christian Wolf R
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):195-208. PubMed ID: 22483295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
    Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
    Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.